Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
DRUG ALERT
Class 2 medicines recallPharmacy and wholesaler level recall
| 01 July 2009 | EL (09)A/17 | Our ref: MDR 58-06/09 |
Dear Healthcare Professional,
Milpharm Limited
Product distributed in Karib Kemi Pharm Limited livery ONLY
Fluoxetine 20mg Capsules
Pack size: 30 Capsules
Milpharm Limited are recalling all unexpired stock of the above product in Karib Kemi Pharm Limited livery only (batches beginning with ‘T’) due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of their contract manufacturer. Please note stock with the same PL number but in different liveries is not affected by this recall.
All unused, unexpired stock of the above batches should be quarantined and returned for credit.
For any Medical Information enquiries related to this case please call Karib Kemi Pharm Limited on 07732 166641 or 07732 166891.
For enquiries related to stock returns and credit please call Karib Kemi Pharm Limited on 07732 166641 or 07732 166891.
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to forward this to relevant clinics, General Practitioners and Community Pharmacists.
Yours faithfully
Alison Bunce
Pharmaceutical Assessor, DMRC
Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary Care Trusts (England)
Class 2 Drug Alert (Action within 48 Hours): Milpharm Limited - Fluoxetine 20mg Capsules - EL (09)A17 
